Last updated on September 2018

A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity


Brief description of study

The purpose of the study is to evaluate the efficacy, tolerability and safety of LIK066 to support dose selection for Phase 3 development in Japanese adults with obesity disease.

Clinical Study Identifier: NCT03320941

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Kawaguchi-sity, Japan
1.22miles

Novartis Pharmaceuticals

Novartis Investigative Site
Toshima-ku, Japan
5.53miles